(Q44183940)

30 November 2017

title

Prophylactic versus therapeutic alpha-blockers after permanent prostate brachytherapy (English)

1 reference

30 November 2017

1 reference

Gregory S Merrick

1

1 reference

30 November 2017

Wayne M Butler

2

1 reference

30 November 2017

Kent E Wallner

3

1 reference

30 November 2017

Jonathan H Lief

4

1 reference

30 November 2017

Robert W Galbreath

5

1 reference

30 November 2017

language of work or name

English

0 references

publication date

1 October 2002

1 reference

30 November 2017

1 reference

30 November 2017

volume

60

1 reference

30 November 2017

issue

4

1 reference

30 November 2017

page(s)

650-655

1 reference

Temporal resolution of urinary morbidity following prostate brachytherapy

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901840-X

7 January 2021

Tumor control and morbidity following transperineal iodine 125 implantation for stage T1/T2 prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901840-X

7 January 2021

Identification of patients at increased risk for prolonged urinary retention following radioactive seed implantation of the prostate.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901840-X

7 January 2021

Comparison of the 5-year outcome and morbidity of three-dimensional conformal radiotherapy versus transperineal permanent iodine-125 implantation for early-stage prostatic cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901840-X

7 January 2021

Short-term morbidity and acceptability of 125iodine implantation for localized carcinoma of the prostate.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901840-X

7 January 2021

Transperineal 125iodine implantation for treatment of clinically localized prostate cancer: 5-year tumor control and morbidity

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901840-X

7 January 2021

Urinary morbidity following ultrasound-guided transperineal prostate seed implantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901840-X

7 January 2021

Identifying the predictors of acute urinary retention following magnetic-resonance-guided prostate brachytherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901840-X

7 January 2021

Five-year biochemical outcome and toxicity with transperineal CT-planned permanent I-125 prostate implantation for patients with localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901840-X

7 January 2021

Acute urinary toxicity following transperineal prostate brachytherapy using a modified Quimby loading method

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901840-X

7 January 2021

Acute urinary morbidity following I-125 interstitial implantation of the prostate gland

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901840-X

7 January 2021

Dosimetry of interstitial brachytherapy sources: recommendations of the AAPM Radiation Therapy Committee Task Group No. 43. American Association of Physicists in Medicine.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901840-X

7 January 2021

Comparison of dose length, area, and volume histograms as quantifiers of urethral dose in prostate brachytherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901840-X

7 January 2021

Relationship between the transition zone index of the prostate gland and urinary morbidity after brachytherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2802%2901840-X

7 January 2021

10.1016/S0090-4295(02)01840-X

Identifiers

DOI

1 reference

30 November 2017

1 reference